Efficacy and Safety of Double‐Filtration Plasmapheresis Versus Efgartigimod in Generalized Myasthenia Gravis: A Single‐Center Retrospective Study

Jingwen Li, Wenbin Wan, Jun Wu, Yufang Mei, Liping Ni, Huiying Qiu, Yan Zhou, Ying Zhang, Bei Zhang, Gang Wang, Yunlan Du, Jieli Geng

Open source

DOI
10.1002/jca.70176
Published
2026-09-20
Container
Journal of Clinical Apheresis
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/jca.70176,
  title = {Efficacy and Safety of Double‐Filtration Plasmapheresis Versus Efgartigimod in Generalized Myasthenia Gravis: A Single‐Center Retrospective Study},
  author = {Jingwen Li and Wenbin Wan and Jun Wu and Yufang Mei and Liping Ni and Huiying Qiu and Yan Zhou and Ying Zhang and Bei Zhang and Gang Wang and Yunlan Du and Jieli Geng},
  year = {2026},
  journal = {Journal of Clinical Apheresis},
  doi = {10.1002/jca.70176},
  url = {https://doi.org/10.1002/jca.70176}
}

RIS

TY  - JOUR
TI  - Efficacy and Safety of Double‐Filtration Plasmapheresis Versus Efgartigimod in Generalized Myasthenia Gravis: A Single‐Center Retrospective Study
AU  - Jingwen Li
AU  - Wenbin Wan
AU  - Jun Wu
AU  - Yufang Mei
AU  - Liping Ni
AU  - Huiying Qiu
AU  - Yan Zhou
AU  - Ying Zhang
AU  - Bei Zhang
AU  - Gang Wang
AU  - Yunlan Du
AU  - Jieli Geng
PY  - 2026
JO  - Journal of Clinical Apheresis
DO  - 10.1002/jca.70176
UR  - https://doi.org/10.1002/jca.70176
ER  - 

APA

Li, J., Wan, W., Wu, J., Mei, Y., Ni, L., Qiu, H., Zhou, Y., Zhang, Y., Zhang, B., Wang, G., Du, Y., & Geng, J. (2026). Efficacy and Safety of Double‐Filtration Plasmapheresis Versus Efgartigimod in Generalized Myasthenia Gravis: A Single‐Center Retrospective Study. Journal of Clinical Apheresis. https://doi.org/10.1002/jca.70176

Source records